Hillstream Biopharma Inc - SIC # 8731 - COMMERCIAL PHY_SICAL AND BIOLOGICAL RESEARCH

Ticker Exchange SIC # Website Latest Ticker
HILS Nasdaq 8731 http://www.hillstreambio.com/

Select one of the four (4) financial statement analysis reports below to view the ratio analysis report for your selected company:

Financial Analysis - Public Company vs Industry Ratio Analysis
Financial Analysis - Public Company
Industry Ratios Analysis
Public Company vs Public Company

Latest Headlines for Hillstream Biopharma Inc

Hillstream BioPharma to Attend the 35th Annual ROTH Conference on March 12-14, 2023 - Feb 28th, 2023 2:45 pm
Hillstream BioPharma Regains Compliance with Nasdaq Listing Minimum Bid Price Rule - Feb 15th, 2023 12:11 pm
Hillstream BioPharma Provides Webcast for its R&D Day on February 14th, 2023 at 10:00am ET - Feb 13th, 2023 9:15 pm
Hillstream BioPharma Signs Exclusive Option Agreement with Applied Biomedical Science Institute (ABSI) to License Technology for HER2 and HER3 to be Developed for Potential Treatments Against Drug Resistant Cancers Including HER2-Positive Metastatic Breast Cancer, Gastric Cancer, Lung Cancer and Ovarian Cancer - Feb 13th, 2023 12:11 pm
In a KRAS G12C-mutated NSCLC cell line, Calu-1, Hillstream BioPharma Demonstrated Significantly Greater Tumor Inhibition Combining Pembrolizumab, an anti-PD-1 antibody, and HSB-1216, a Ferroptosis Inducer - Feb 10th, 2023 12:17 pm
Hillstream BioPharma Announces Acceptance of Abstract at AACR 2023 Annual Meeting Highlighting HSB-510 as Novel Bi-functional Inhibitor for Solid Tumors & Leukemias - Feb 8th, 2023 12:11 pm
Hillstream BioPharma to Host Virtual R&D Day to Showcase its Emerging Immuno-oncology Pipeline Targeting Drug-Resistant Cancers - Feb 6th, 2023 12:00 pm
Why Are Hillstream BioPharma Shares Trading Over 100% Today? - Jan 31st, 2023 3:41 pm
Hillstream BioPharma Signs an Exclusive Option Agreement to Advance Next-Generation Anti-MUC1-C Agents for Drug Resistant Cancers - Jan 31st, 2023 12:11 pm
Hillstream BioPharma to Present at the Virtual Sidoti Micro-Cap Conference on January 18-19, 2023 - Jan 17th, 2023 4:29 pm
Sidoti's January Micro-Cap Conference - Jan 17th, 2023 3:00 pm
Insiders who purchased Hillstream BioPharma, Inc. (NASDAQ:HILS) stock last year recover some losses which currently stand at US$86k - Dec 12th, 2022 10:39 am
Hillstream BioPharma Announces Development of Proprietary Targeted Biologics, Knob Quatrabodies™ (HSB-1940) against PD-1, by combining Quatramers™ with OmniAb’s Picobodies™, via a Collaboration Agreement, against Novel, Unreachable and Undruggable Epitopes in High Value Validated Targets - Dec 1st, 2022 1:47 pm
Hillstream BioPharma to Present at the RHK Capital Disruptive Growth Conference on December 5-6, 2022 - Nov 22nd, 2022 11:30 am
Hillstream’s New Anti-Cancer Mechanism Quatramer-based Ferroptosis Inducer, HSB-1216 Abstract Available for Viewing at EORTC-NCI-AACR Symposium - Oct 18th, 2022 12:47 pm
Hillstream BioPharma, Inc. to Present at Upcoming Investor Conferences - Oct 6th, 2022 12:47 pm
Hillstream BioPharma to Participate in the Fierce Biotech Summit on September 19-20 - Sep 14th, 2022 12:47 pm
Hillstream BioPharma to Attend the 12th Annual World Orphan Drug Congress USA on July 11-13 - Jul 8th, 2022 12:17 pm
A number of insiders bought Hillstream BioPharma, Inc. (NASDAQ:HILS) stock last year, which is great news for shareholders - Jul 4th, 2022 7:35 pm
Hillstream BioPharma Announces Collaboration with Sapien Biosciences in Cancer Treatments - Jun 27th, 2022 12:27 pm